This index provides a clean navigation layer for the `experiments` section of NeuroWiki. It currently lists all experiment pages across multiple disease areas, organized alphabetically by category.
_Total: 187 pages_
All Pages
A
...
Overview
Mermaid diagram (expand to render)
This index provides a clean navigation layer for the `experiments` section of NeuroWiki. It currently lists all experiment pages across multiple disease areas, organized alphabetically by category.
_Total: 187 pages_
All Pages
A
[4R-Tau Targeting Therapies for PSP and CBS](/experiments/4r-tau-targeting-psp-cbs)
[AAV Serotype Comparison for LRRK2 Knockdown in PD](/experiments/aav-serotype-lrrk2-knockdown)
[AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Therapy](/experiments/aaav-serotype-lrrk2-gene-therapy)
[AAV-LRRK2 Gene Therapy IND-Enabling Study Design](/experiments/lrrk2-aav-ind-enabling-study)
[AAV-LRRK2 IND-Enabling Study Design](/experiments/aav-lrrk2-ind-enabling-studies)
[AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Positive Individuals Never Develop Dementia](/experiments/ad-amyloid-resilient-phenotype)
[Selective Vulnerability of Dopaminergic Neurons — Mechanism and Protection](/experiments/dopaminergic-neuron-selective-vulnerability-pd)
E
[EBV as Causal Trigger vs Necessary Co-factor in MS Neurodegeneration](/experiments/ebv-causal-trigger-multiple-sclerosis)
[Endocannabinoid System Dysfunction Validation in Parkinson's Disease](/experiments/endocannabinoid-system-dysfunction-parkinsons)
[Environmental Exposure Causal Attribution in ALS — Experiment Design](/experiments/environmental-exposure-als)
[Epigenetic Clocks in Neurodegeneration — Causal Drivers or Passive Markers](/experiments/epigenetic-clocks-neurodegeneration)
[Epigenetic Dysregulation in Huntington's Disease — Therapeutic Targeting](/experiments/epigenetic-dysregulation-hd)
[Epigenetic Dysregulation Validation in Parkinson's Disease](/experiments/epigenetic-dysregulation-parkinsons)
[Epigenetic Regulation Dysfunction in Alzheimer's and Parkinson's Disease](/experiments/epigenetic-regulation-neurodegeneration)
[ER-Golgi Secretory Pathway Dysfunction in PD - Experiment Design](/experiments/er-golgi-secretory-pathway-parkinsons)
[Exercise-BDNF-Mitophagy Biomarker Study in PD](/experiments/exercise-bdnf-mitophagy-parkinsons)
[Extracellular Vesicle-Mediated Synuclein Propagation in Parkinson's Disease](/experiments/extracellular-vesicle-synuclein-propagation-parkinsons)
F
[Ferroptosis Validation in Parkinson's Disease](/experiments/ferroptosis-parkinsons)
[Frontal and Temporal Lobe Selective Vulnerability in FTD — Mechanisms and Therapeutic Targets](/experiments/frontal-temporal-selective-vulnerability-ftd)
[FTD Microglia Role: Protective vs Destructive Mechanism Study](/experiments/ftd-microglia-role-protective-destructive)
[FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation](/experiments/ftld-tau-tdp-biomarker-differentiation)
G
[Gap Junction Dysfunction Validation in Parkinson's Disease](/experiments/gap-junction-dysfunction-parkinsons)
[Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown](/experiments/lrrk2-aav-gene-therapy-comparison)
[GLP-1 Agonist Neuroprotection Mechanism in PD](/experiments/glp1-agonist-pd-mechanism)
[GLP-1 Agonist Responder Prediction Study — Precision Medicine for Neuroprotection in PD](/experiments/glp1-responder-prediction-pd)
[GRN Carrier Resilience: Why Some Mutation Carriers Remain Asymptomatic](/experiments/grn-carrier-resilience-ftd)
[Gut-Brain Axis Pathogenesis in Parkinson's Disease — Mechanism and Intervention](/experiments/gut-brain-axis-parkinsons-pathogenesis)
[Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propagation](/experiments/microbiome-alpha-synuclein-propagation)
[Gut-Immune-Brain Axis Intervention Trial in Parkinson's Disease](/experiments/gut-immune-brain-axis-parkinsons)
[Glymphatic-Circadian Axis Enhancement Therapy for Parkinson's Disease](/experiments/glymphatic-circadian-axis-parkinsons)
I
[Iron Dyshomeostasis in MSA Pathogenesis Experiment](/experiments/iron-dyshomeostasis-msa-pathogenesis)